IL5 and Alzheimer disease: In contrast, the level of IL-33 mRNA was less upregulated by TLR2 signaling in AD patients than that in healthy controls (Fig. 3d) while TLR2/1 ligand Pam3CSK4 induced dramatically higher level of IL-5 mRNA in AD patients (Fig. 3a).